Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing

  • Published Date:

    Mar 2018

  • Source:
    Emerg Infect Dis. 24(3):584-587.
  • Language:
    English
Filetype[PDF-1.06 MB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.15 MB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    January 16, 2009
    Source:
    MMWR. Morbidity and mortality weekly report. 2009; 58(1):7-10.
    Description:
    CDC has reported previously surveillance data of severe liver injury in patients treated for latent tuberculosis infection (LTBI) with a daily and twi...
    Status:
    current
    File Type:
    Filetype[PDF - 1.15 MB]
    File Type:
    Filetype[PDF - 1.15 MB]
  2. Filetype[PDF - 101.40 KB]
    Personal Author:
    Bingham, Andrea M. ; Cone, Marshall ; ...
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    May 13, 2016
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 65, no. 18, p. 475-8
    Description:
    On May 10, 2016, this report was posted online as an MMWR Early Release.In May 2015, Zika virus was reported to be circulating in Brazil. This was the...
    File Type:
    Filetype[PDF - 101.40 KB]
    File Type:
    Filetype[PDF - 101.40 KB]
  3. Filetype[PDF - 32.88 KB]
    Published Date:
    March 17, 2016
    Description:
    Dear Health Care Provider:The U.S Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to authorize the use of the Cente...
    File Type:
    Filetype[PDF - 32.88 KB]
    File Type:
    Filetype[PDF - 32.88 KB]
  4. Filetype[PDF - 151.91 KB]
    Personal Author:
    Schalla, William O. ; Schulte, Joann M. ;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.). Public Health Practice Program Office. Division of Laboratory Systems. ; ...
    Published Date:
    November 16, 2001
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 50, no. RR-20
    Description:
    Monitoring human immunodeficiency virus type 1 (HIV-1) ribonucleic acid levels (also known as HIV viral load) has become the standard of care for moni...
    Status:
    current
    File Type:
    Filetype[PDF - 151.91 KB]
    File Type:
    Filetype[PDF - 151.91 KB]
  5. Filetype[PDF - 717.88 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    March 2, 2015
    Description:
    Dear Health Care Provider:The U.S Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to authorize the use of the Cente...
    File Type:
    Filetype[PDF - 717.88 KB]
    File Type:
    Filetype[PDF - 717.88 KB]